The FDA has approved a new treatment for adolescents between the ages of 13 and 17 years who are diagnosed with schizophrenia.
Researchers profiled which young people may do well after first-episode psychosis without medication.
These study results indicate that early intervention with low doses of metformin in patients with few metabolic abnormalities may be beneficial.
Targeting negative symptoms in patients with schizophrenia may be more effective in improving patients' QoL.
Pretreatment cardiometabolic status to be taken into consideration for treatment of first episode psychosis.
Inability to interpret facial expressions may exacerbate psychotic symptoms, either indirectly via social defeat or directly by creating confusing interpersonal experiences.
Cardiac safety is integral to child and adolescent antipsychotic therapy.
Patients with early schizophrenia may have already started down the road to diabetes, even prior to actual diagnosis.
Both immediate and gradual discontinuation of the current antipsychotic medication are viable treatment options.
Clinical practice guidelines are important resources for early intervention in a first episode of schizophrenia.
Psychiatry Advisor Articles
- Naltrexone-Assisted Detox vs Buprenorphine Taper for Opioid Dependence
- Suicide Prevention and Intervention: Cross-Cultural Perspectives
- Pediatric Patients Should Undergo Electrocardiogram Assessment Before Antipsychotic Treatment
- Which Antidepressants May Cause Birth Defects?
- Health Effects and Therapeutic Benefits of Cannabis